|
Re: Resverlogix Announces Publication in High-impact Peer-reviewed Journal – Medicinal Research Reviews
|
7
|
Resverlogix Corp.
|
Sep 15, 2020 09:31PM
|
|
Re: Q4 2019 Events
|
7
|
Resverlogix Corp.
|
Oct 12, 2019 07:13AM
|
|
Re: Apabetalone downregulates factors and pathways associated with vascular calcification
|
7
|
Resverlogix Corp.
|
Nov 20, 2018 02:21PM
|
|
Re: Zenith AGM Corporation Update Slides and Webcast
|
7
|
Zenith Epigenetics
|
Oct 31, 2019 10:54PM
|
|
Re: Some idle speculation I just can't resist.....
|
7
|
Resverlogix Corp.
|
Aug 26, 2016 08:42AM
|
|
RVX tweet from Nov 7th
|
7
|
Resverlogix Corp.
|
Nov 12, 2016 03:44PM
|
|
BRD4 regulates metastatic potential of castration-resistant prostate cancer through AHNAK
|
7
|
Zenith Epigenetics
|
May 20, 2019 05:09PM
|
|
Apabetalone Treatment of CKD Patientsis Associated with Favorable Kidney Function and Alkaline Phosphatase Profile
|
7
|
Resverlogix Corp.
|
Mar 23, 2018 10:02AM
|
|
Inhibition of IL-1β by Canakinumab reduces MACE rates in high risk CKD patients
|
7
|
Resverlogix Corp.
|
May 24, 2018 08:18PM
|
|
Constellation Pharmaceuticals Readies $80 Million IPO Plans
|
7
|
Zenith Epigenetics
|
Jul 20, 2018 10:14AM
|
|
Re: 3 point MACE vs 5 point MACE
|
7
|
Resverlogix Corp.
|
Nov 02, 2018 05:50PM
|
|
Resverlogix ACC 2018 Abstract
|
7
|
Resverlogix Corp.
|
Feb 27, 2018 02:22PM
|
|
Re: Resverlogix Presents at Clinical Trials in Alzheimer’s Disease (CTAD) Asia 2018
|
7
|
Resverlogix Corp.
|
Sep 04, 2018 08:58AM
|
|
Phase 1b/2 trial expected to initiate 1Q 2019
|
7
|
Zenith Epigenetics
|
Jan 04, 2019 10:51AM
|
|
Re: AHA 2020
|
7
|
Resverlogix Corp.
|
Sep 17, 2020 03:04PM
|
|
EAS tweet
|
7
|
Resverlogix Corp.
|
Feb 25, 2019 11:48AM
|
|
Re: EASD 2019 Sept 16-20, 2019
|
7
|
Resverlogix Corp.
|
Sep 17, 2019 09:56AM
|
|
Re: Upcoming Presentations
|
7
|
Resverlogix Corp.
|
Oct 19, 2020 03:00PM
|
|
Re: Looking at the chart...introducing the bullish channel
|
7
|
Resverlogix Corp.
|
Sep 21, 2018 06:00PM
|
|
Re: QBI COVID-19 research results
|
7
|
Resverlogix Corp.
|
Apr 30, 2020 05:14PM
|
